Bio Green Med Solution, Inc. last reported quarterly results on Aug 14, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $336,000 (+8300.0% year over year). It usually reports 44–45 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 12, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Nov 13, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 44–45 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 14, 2026
45 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
0
+8300.0%
|
-0
+69.3%
|
—
|
|
May 14, 2026
44 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
1
+2582.8%
|
-0
-143.2%
|
—
|
|
Nov 13, 2025
44 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
0
+710.0%
|
-1
+49.5%
|
-1.31
|
|
Aug 13, 2025
44 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
—
|
-1
|
-0.98
|
|
Apr 2, 2025
2 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
—
|
-0
+97.3%
|
0.00
+100.0%
|
|
Nov 12, 2024
43 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
0
-37.5%
|
-2
+67.6%
|
—
|
|
Aug 14, 2024
45 days after quarter end
|
—
ended Jun 30, 2024
|
—
|
—
|
—
|
|
May 14, 2024
44 days after quarter end
|
—
ended Mar 31, 2024
|
—
|
—
|
—
|
Company profile
- Industry
- Wholesale-Durable Goods, NEC (SIC 5099)
- Listed as
- BGMS (Nasdaq), BGMSP (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Berkeley Heights, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1130166
- Former names
- Cyclacel Pharmaceuticals, Inc. (until Sep 12, 2025); XCYTE THERAPIES INC (until Mar 24, 2006)
Other Wholesale-Durable Goods, NEC companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.